Cargando…

MicroRNA and Alternative mRNA Splicing Events in Cancer Drug Response/Resistance: Potent Therapeutic Targets

Cancer is a multifaceted disease that involves several molecular mechanisms including changes in gene expression. Two important processes altered in cancer that lead to changes in gene expression include altered microRNA (miRNA) expression and aberrant splicing events. MiRNAs are short non-coding RN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marima, Rahaba, Francies, Flavia Zita, Hull, Rodney, Molefi, Thulo, Oyomno, Meryl, Khanyile, Richard, Mbatha, Sikhumbuzo, Mabongo, Mzubanzi, Owen Bates, David, Dlamini, Zodwa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698559/ https://www.ncbi.nlm.nih.gov/pubmed/34944633 http://dx.doi.org/10.3390/biomedicines9121818

Ejemplares similares

Genetic Drivers of Head and Neck Squamous Cell Carcinoma: Aberrant Splicing Events, Mutational Burden, HPV Infection and Future Targets
por: Dlamini, Zodwa, et al.
Publicado: (2021)

Artificial intelligence (AI) and big data in cancer and precision oncology
por: Dlamini, Zodwa, et al.
Publicado: (2020)

Colorectal Cancer Genetics, Incidence and Risk Factors: In Search for Targeted Therapies
por: Hull, Rodney, et al.
Publicado: (2020)

Viral Encoded miRNAs in Tumorigenesis: Theranostic Opportunities in Precision Oncology
por: Hull, Rodney, et al.
Publicado: (2022)

Role of Precision Oncology in Type II Endometrial and Prostate Cancers in the African Population: Global Cancer Genomics Disparities
por: Marima, Rahaba, et al.
Publicado: (2022)

Competing Endogenous RNA (ceRNA) Networks and Splicing Switches in Cervical Cancer: HPV Oncogenesis, Clinical Significance and Therapeutic Opportunities
por: Basera, Afra, et al.
Publicado: (2022)

Genomic Interplay between Neoneurogenesis and Neoangiogenesis in Carcinogenesis: Therapeutic Interventions
por: Dlamini, Zodwa, et al.
Publicado: (2023)

Alternative Splicing Events and Their Clinical Significance in Colorectal Cancer: Targeted Therapeutic Opportunities
por: Manabile, Mosebo Armstrong, et al.
Publicado: (2023)

Efavirenz induces DNA damage response pathway in lung cancer
por: Marima, Rahaba, et al.
Publicado: (2020)

Efavirenz and Lopinavir/Ritonavir Alter Cell Cycle Regulation in Lung Cancer
por: Marima, Rahaba, et al.
Publicado: (2020)

The profiling, identification, quantification and analysis of differentially expressed genes (DEGs) in response to drug treatment in lung cancer
por: Marima, Rahaba, et al.
Publicado: (2021)

Exploiting the Molecular Basis of Oesophageal Cancer for Targeted Therapies and Biomarkers for Drug Response: Guiding Clinical Decision-Making
por: Mbatha, Sikhumbuzo, et al.
Publicado: (2022)

Aberrant Splicing Events and Epigenetics in Viral Oncogenomics: Current Therapeutic Strategies
por: Francies, Flavia Zita, et al.
Publicado: (2021)

HIV-Associated Cancer Biomarkers: A Requirement for Early Diagnosis
por: Dlamini, Zodwa, et al.
Publicado: (2021)

The Catastrophic HPV/HIV Dual Viral Oncogenomics in Concert with Dysregulated Alternative Splicing in Cervical Cancer
por: Marima, Rahaba, et al.
Publicado: (2021)

Overcoming the Challenges of Phytochemicals in Triple Negative Breast Cancer Therapy: The Path Forward
por: Alaouna, Mohammed, et al.
Publicado: (2023)

Prognostic Alternative Splicing Signatures in Esophageal Carcinoma
por: Dlamini, Zodwa, et al.
Publicado: (2021)

Prostate Cancer Disparities and Management in Southern Africa: Insights into Practices, Norms and Values
por: Marima, Rahaba, et al.
Publicado: (2022)

Many Voices in a Choir: Tumor-Induced Neurogenesis and Neuronal Driven Alternative Splicing Sound Like Suspects in Tumor Growth and Dissemination
por: Dlamini, Zodwa, et al.
Publicado: (2021)

Splicing Genomics Events in Cervical Cancer: Insights for Phenotypic Stratification and Biomarker Potency
por: Francies, Flavia Zita, et al.
Publicado: (2021)

Role and Merits of Green Based Nanocarriers in Cancer Treatment
por: Elbagory, Abdulrahman M., et al.
Publicado: (2021)

Can the HIV-1 splicing machinery be targeted for drug discovery?
por: Dlamini, Zodwa, et al.
Publicado: (2017)

The role played by alternative splicing in antigenic variability in human endo-parasites
por: Hull, Rodney, et al.
Publicado: (2014)

Dissecting Microbiome-Derived SCFAs in Prostate Cancer: Analyzing Gut Microbiota, Racial Disparities, and Epigenetic Mechanisms
por: Miya, Thabiso Victor, et al.
Publicado: (2023)

In Silico Bioinformatics Analysis on the Role of Long Non-Coding RNAs as Drivers and Gatekeepers of Androgen-Independent Prostate Cancer Using LNCaP and PC-3 Cells
por: Mbeje, Mandisa, et al.
Publicado: (2023)

Abnormalities in Alternative Splicing of Apoptotic Genes and Cardiovascular Diseases
por: Dlamini, Zodwa, et al.
Publicado: (2015)

Regulation of alternative splicing in obesity-induced hypertension
por: Dlamini, Zodwa, et al.
Publicado: (2019)

Abnormalities in alternative splicing of angiogenesis-related genes and their role in HIV-related cancers
por: Mthembu, Nonkululeko N, et al.
Publicado: (2017)

Microbiomics in Collusion with the Nervous System in Carcinogenesis: Diagnosis, Pathogenesis and Treatment
por: Hull, Rodney, et al.
Publicado: (2021)

Human Immunodeficiency Virus-1 (HIV-1)-Mediated Apoptosis: New Therapeutic Targets
por: Mbita, Zukile, et al.
Publicado: (2014)

LncRNAs and the Angiogenic Switch in Cancer: Clinical Significance and Therapeutic Opportunities
por: Mabeta, Peace, et al.
Publicado: (2022)

MicroRNA Interrelated Epithelial Mesenchymal Transition (EMT) in Glioblastoma
por: Setlai, Botle Precious, et al.
Publicado: (2022)

The Role of MicroRNAs in Kidney Disease
por: Mukhadi, Sydwell, et al.
Publicado: (2015)

Esophageal cancer genetics in South Africa
por: Alaouna, Mohammed, et al.
Publicado: (2019)

Translocator Protein (TSPO) as a Potential Biomarker in Human Cancers
por: Bhoola, Nimisha H., et al.
Publicado: (2018)

Reports of Plant-Derived Nanoparticles for Prostate Cancer Therapy
por: Elbagory, Abdulrahman M., et al.
Publicado: (2023)

RBBP6 Is Abundantly Expressed in Human Cervical Carcinoma and May Be Implicated in Its Malignant Progression
por: Dlamini, Zodwa, et al.
Publicado: (2019)

Immunomodulatory Gene-Splicing Dysregulation in Tumorigenesis: Unmasking the Complexity
por: Maebele, Lorraine Tshegofatso, et al.
Publicado: (2023)

Immunosuppressive Signaling Pathways as Targeted Cancer Therapies
por: Setlai, Botle Precious, et al.
Publicado: (2022)

The splicing regulators Tra and Tra2 are unusually potent activators of pre-mRNA splicing
por: Sciabica, Kathryn S., et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_05cobde8j3m5230focrm3drgm7